Dr. Nallasivam Palanisamy, Henry Ford Cancer Institute, discusses his discovery of the first pseudogene-associated recurrent gene fusion in cancer and the potential for this robust biomarker for application beyond prostate cancer
The trial will study the use of ruxolitinib, a JAK inhibitor, to investigate its effect on reducing complications in deteriorating COVID-19 patients
Dr. Sylvia Boj discusses the advantages of organoids and how these 3D tissue cultures have enormous potential to revolutionize how we treat patients and predict therapeutic response
Catch up on this on-demand webinar to learn how researchers at LifeArc are investigating a novel approach to targeting ALK-expressing neuroblastoma cells
Join this webinar to find out how 3D cell culture overcomes the limitations of traditional 2D culture
Immunovia will receive fresh blood samples from the pharmaceutical partner for analysis
Discover how one lab is using patient-derived pancreatic organoids to deliver personalized treatments
Study done at the University of Cambridge suggests a way to predict prognosis and most effective treatment in cancer
AI-powered solution to enhance diagnostic efficiency, streamline clinical trials, and improve patient outcomes across global pathology networks
Based on single-sample testing the VIDAS Anti-CHIKUNGUNYA IgM and IgG are easy to use and accessible to all laboratories
These findings are the first evidence that a pre-emptive intervention during infancy could lead to a child falling below the threshold for a clinical diagnosis of autism
With cases rising among younger adults in India, researchers race to develop predictive diagnostics and immune-informed therapies
Meet Dr. Ron Daniels, a #CLINICAL24 Ambassador, and discover his tireless fight to improve sepsis diagnostics and care
